Literature DB >> 407104

The effect of danazol on anterior pituitary function.

P Franchimont, C Cramilion.   

Abstract

Danazol was given in a daily dose of 600 mg for 15 days to five postmenopausal women and five normal adult men. The basal levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), thyroid-stimulating hormone (TSH), prolactin (PRL), and cortisol were determined for 3 days before treatment and during the last 3 days of treatment. A combined intravenous injection of 25 micrograms of gonadotropin-releasing hormone (GnRH) and 200 micrograms of thyrotropin-releasing hormone (TRH) was also given before and on the last day of treatment to each subject. Danazol reduces basal levels of FSH and LH and their cumulative response to GnRH but exercises no significant effect on either basal levels of TSH or PRL or their response to TRH, nor does it modify basal cortisol secretion.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 407104

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

1.  Hyperglucagonaemia and treatment with danazol for systemic lupus erythematosus.

Authors:  J David
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-26

2.  The effect of danazol on the pituitary function, thyroid function, and mastodynia.

Authors:  F Peters; G Reck; G Zimmermann; M Breckwoldt
Journal:  Arch Gynecol       Date:  1980

Review 3.  Pharmacology and pharmacokinetics of danazol.

Authors:  G O Potts; H P Schane; J Edelson
Journal:  Drugs       Date:  1980-05       Impact factor: 9.546

4.  Danazol in the treatment of gynaecomastia.

Authors:  R Buckle
Journal:  Drugs       Date:  1980-05       Impact factor: 9.546

5.  Does TSH Reliably Detect Hypothyroid Patients?

Authors:  C Ling; Q Sun; J Khang; M Felipa Lastarria; J Strong; B Stolze; X Yu; T P Parikh; M A Waldman; K Welsh; J Jonklaas; L Masika; S J Soldin
Journal:  Ann Thyroid Res       Date:  2018-02-20

6.  Tamoxifen, aminoglutethimide and danazol: effect of therapy on hormones in post-menopausal patients with breast cancer.

Authors:  R C Coombes; T J Powles; L H Rees; W A Ratcliffe; A G Nash; M Henk; H T Ford; J C Gazet; A M Neville
Journal:  Br J Cancer       Date:  1982-07       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.